Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clock Genes Influence Metabolism: A First Link With Glucose Production

This article was originally published in Start Up

Executive Summary

It's common sense that Circadian rhythms manifest at the molecular level, given the obviously different metabolic functions while awake versus when asleep. Now, a group has shown that one of the body's "clock genes" helps regulate the production of new glucose in the liver. The findings could be applied to the discovery of novel treatments for type 2 diabetes and because the mechanism may also regulate signaling activities in other cell types, potentially alter the course of other diseases.

You may also be interested in...

Sleep Apnea Devices: The Changing Of The Guard

The current specialty-dominated care paradigm for sleep apnea can't scale-up to meet the demands of an enormous and serious chronic disease. New companies help move diagnosis and treatment to the physicians that see patients first.

Marrying Glucagon with GLP-1 to Treat Obesity

Because glucagon raises blood glucose in the liver, it's counter-intuitive to think of it as the basis for a strategy to treat obesity and its associated consequences, including adult onset diabetes. But a research team has shown that a single-molecule "co-agonist" of glucagon and GLP-1 normalizes glucose tolerance and reduces body fat and weight in preclinical models. This molecular-level polypharmacy is particularly appealing in metabolic disease, where single mechanisms tend to offer only modest therapeutic effects.

Mining the Mitochondria for Clues to Cell Survival Mechanisms

Researchers have identified a protein in the mitochondria -- where cells generate the energy needed to drive biological processes -- that is dramatically upregulated by nutrient restriction. It appears to protect the cell from stress, in keeping with observations that caloric restriction diets slow aging. The researchers go on to show that a set of other proteins activated in turn by this process may be targets for the development of therapies for neurodegenerative diseases and diabetes.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts